+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

Virtual Oncology Market - Global Strategic Business Report - Product Thumbnail Image

Virtual Oncology Market - Global Strategic Business Report

  • Report
  • May 2026
  • 364 Pages
  • Global
From
From
From
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • May 2026
  • 246 Pages
  • Global
From
From
From
From
From
From
From
From
Oncology NGS Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology NGS Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Soft Tissue Sarcomas Market - Global Forecast 2026-2032 - Product Thumbnail Image

Soft Tissue Sarcomas Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
From
Oncology API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oncology API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
Actinium-225 Market - Global Forecast 2025-2030 - Product Thumbnail Image

Actinium-225 Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Cancer Ablation Equipment Market - Global Forecast to 2030 - Product Thumbnail Image

Cancer Ablation Equipment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more